Claudin proteins as emerging therapeutic targets for solid tumours
Antonio Saviano, Alberto Toso, Samuel J. Klempner & Thomas F. Baumert
Antonio Saviano, Alberto Toso, Samuel J. Klempner & Thomas F. Baumert
This Review by Abdel-Hafiz et al. describes the current and emerging evidence that loss of the Y chromosome is linked to susceptibility, progression and poor outcomes in multiple cancer types, as well as its potential use as a biomarker for prognosis and precision therapy.